Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 671

Similar articles for PubMed (Select 23325525)

1.

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators.

Circulation. 2013 Feb 12;127(6):720-9. doi: 10.1161/CIRCULATIONAHA.112.114389. Epub 2013 Jan 16.

2.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.

J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6. doi: 10.1016/j.jacc.2013.03.035. Epub 2013 Apr 10.

3.

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr.

J Am Coll Cardiol. 2013 Apr 30;61(17):1790-8. doi: 10.1016/j.jacc.2013.01.061. Epub 2013 Feb 28.

4.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

6.

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D; PROTECT AF Steering Committee and Investigators.

JAMA. 2014 Nov 19;312(19):1988-98. doi: 10.1001/jama.2014.15192. Erratum in: JAMA. 2015 Mar 10;313(10):1061.

PMID:
25399274
7.
8.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators.

Lancet. 2009 Aug 15;374(9689):534-42. doi: 10.1016/S0140-6736(09)61343-X. Erratum in: Lancet. 2009 Nov 7;374(9701):1596.

PMID:
19683639
9.

Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.

Gangireddy SR, Halperin JL, Fuster V, Reddy VY.

Eur Heart J. 2012 Nov;33(21):2700-8. doi: 10.1093/eurheartj/ehs292. Epub 2012 Sep 24.

10.

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV.

J Vis Exp. 2013 Feb 26;(72):e3818. doi: 10.3791/3818.

11.

The WATCHMAN left atrial appendage closure device for atrial fibrillation.

Möbius-Winkler S, Sandri M, Mangner N, Lurz P, Dähnert I, Schuler G.

J Vis Exp. 2012 Feb 28;(60). pii: 3671. doi: 10.3791/3671.

12.
13.

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.

Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.

Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.

PMID:
23973952
14.

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M.

JACC Cardiovasc Interv. 2009 Jul;2(7):594-600. doi: 10.1016/j.jcin.2009.05.005.

15.

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.

Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM; ROCKET AF Steering Committee and Investigators.

Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3.

16.

Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.

Landmesser U, Holmes DR Jr.

Eur Heart J. 2012 Mar;33(6):698-704. doi: 10.1093/eurheartj/ehr393. Epub 2011 Oct 31. Review.

17.

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.

Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY.

J Am Coll Cardiol. 2015 Jun 23;65(24):2614-23. doi: 10.1016/j.jacc.2015.04.025.

PMID:
26088300
18.

Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.

Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR.

J Am Coll Cardiol. 2007 Apr 3;49(13):1490-5. Epub 2007 Mar 21.

19.

Left atrial appendage closure: a new technique for clinical practice.

John Camm A, Colombo A, Corbucci G, Padeletti L.

Heart Rhythm. 2014 Mar;11(3):514-21. doi: 10.1016/j.hrthm.2013.11.030. Epub 2013 Nov 28. Review.

20.

Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.

Möbius-Winkler S, Schuler GC, Sick PB.

Curr Opin Neurol. 2008 Feb;21(1):64-9. doi: 10.1097/WCO.0b013e3282f419b6. Review.

PMID:
18180653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk